Pharma Tariffs yet to Emerge as Trump Seeks More Deals

Pharma tariffs yet to emerge as Trump seeks more deals

Donald Trump looks set to delay the introduction of his tariffs on pharma imports in order to negotiate more deals with drugmakers on drug pricing.

European futures higher and Trump delays pharma tariffs - Newsquawk Europe Market Open

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Trump holding off on pharma tariffs to negotiate more deals

Pfizer's drug price cuts and the president's new TrumpRx site could lead to more drugmakers cutting deals with the administration to avoid tariffs. Read more here.

How Trump is using leverage to sway companies into making deals

The Trump administration is pursuing deals across up to 30 industries, involving dozens of companies deemed critical to national or economic security, Reuters reports.  In some cases, the administration is offering tariff relief in exchange for concessions, revenue guarantees, or taking equity stakes in troubled companies, among other types of help. The fast-paced dealmaking is designed to deliver political wins for U.S. President Donald Trump b…